We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLAB icon
11101
PUT
Photronics
PLAB
$1.96B
$303K ﹤0.01%
22,900
+6,500
+40% +$85K
OLOX
11102
PUT
Olenox Industries
OLOX
$3.7M
$303K ﹤0.01%
+9
New +$214K
SPXV icon
11103
ProShares S&P 500 ex-Health Care ETF
SPXV
$41.7M
$303K ﹤0.01%
+6,702
New +$295K
NTBL
11104
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$303K ﹤0.01%
+3,619
New +$274K
GPP
11105
PUT
DELISTED
Green Plains Partners LP
GPP
$303K ﹤0.01%
23,700
-29,400
-55% -$359K
GXIIW
11106
DELISTED
GX Acquisition Corp. II Warrant
GXIIW
$303K ﹤0.01%
+329,327
New +$260K
TBSAW
11107
DELISTED
TB SA Acquisition Corp Warrant
TBSAW
$303K ﹤0.01%
+299,999
New +$252K
ABM icon
11108
CALL
ABM Industries
ABM
$2.82B
$302K ﹤0.01%
6,800
+1,600
+31% +$80.3K
CASS icon
11109
PUT
Cass Information Systems
CASS
$748M
$302K ﹤0.01%
+7,400
New +$333K
CRDF icon
11110
CALL
Cardiff Oncology
CRDF
$74.9M
$302K ﹤0.01%
45,400
-78,900
-63% -$669K
ENLV icon
11111
PUT
Enlivex Ltd
ENLV
$26.6M
$302K ﹤0.01%
2,260
-60
-3% -$9.03K
FBK icon
11112
CALL
FB Financial Corp
FBK
$3.09B
$302K ﹤0.01%
8,100
-13,300
-62% -$552K
MNTK icon
11113
Montauk Renewables
MNTK
$268M
$302K ﹤0.01%
+39,319
New +$377K
MTA
11114
PUT
Metalla Royalty & Streaming
MTA
$912M
$302K ﹤0.01%
35,300
+14,000
+66% +$136K
NWSA icon
11115
PUT
News Corp Class A
NWSA
$15.8B
$302K ﹤0.01%
11,700
-14,000
-54% -$369K
TVTX icon
11116
CALL
Travere Therapeutics
TVTX
$5.86B
$302K ﹤0.01%
20,700
+1,900
+10% +$37.5K
XERS icon
11117
Xeris Biopharma Holdings
XERS
$1.57B
$302K ﹤0.01%
74,242
-33,820
-31% -$129K
AAC.WS
11118
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$302K ﹤0.01%
241,942
-13,054
-5% -$13.8K
AVNW icon
11119
CALL
Aviat Networks
AVNW
$287M
$301K ﹤0.01%
+9,200
New +$320K
CBZ icon
11120
CBIZ
CBZ
$2.96B
$301K ﹤0.01%
9,189
-3,339
-27% -$112K
GDYN icon
11121
CALL
Grid Dynamics Holdings
GDYN
$629M
$301K ﹤0.01%
+20,000
New +$313K
GERN icon
11122
Geron
GERN
$943M
$301K ﹤0.01%
213,536
+126,733
+146% +$184K
TCRT icon
11123
PUT
Alaunos Therapeutics
TCRT
$4.71M
$301K ﹤0.01%
760
-20
-3% -$9.34K
USPH icon
11124
CALL
US Physical Therapy
USPH
$1.21B
$301K ﹤0.01%
2,600
-14,700
-85% -$1.69M
ATHX
11125
PUT
DELISTED
Athersys, Inc. Common Stock
ATHX
$301K ﹤0.01%
8,356
-488
-6% -$20.1K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.